The succinate receptor (SUCNR1) hasemerged as a potentialtargetfor the treatment of various metabolic and inflammatory diseases,including hypertension, inflammatory bowel disease, and rheumatoidarthritis. Here, SUCNR1 is linked to hypertensive disorder.